PureHealth Announces Strong Financial Results and Proposed Dividend
In a remarkable display of financial performance, PureHealth reported a net profit of USD 550 million for the fiscal year 2025, reflecting a 17.7% increase compared to the previous year. This impressive growth is attributed to the strong performance in both the Healthcare and Insurance sectors, showcasing healthy trends across localized and international markets.
Significant Revenue Growth
The organization achieved revenues of USD 7.4 billion, marking a 5.7% year-on-year increase. The strong results from the Healthcare and Insurance verticals laid the foundation for this growth. EBITDA rose by 16.1% to USD 1.3 billion, fueled by efficiency improvements and the successful integration of Hellenic Healthcare Group, which was acquired recently.
Proposed Dividend Highlights
Building on this financial success, PureHealth proposed a cash dividend of USD 163 million for FY 2025, which accounts for approximately 30% of their net profit. This anticipated dividend, contingent on regulatory and shareholder approvals, is to be paid in two equal semi-annual installments. It reflects the organization’s strong balance sheet, consistent earnings, and sustainable cash generation practices.
Strategic Positioning and Outlook
PureHealth's strategy continues to focus on expanding its local and international footprint. The company operates across several regions, including the USA, UK, Greece, and Cyprus, bolstered by an increase in patient volume and enhanced clinical capacities. This growth positions PureHealth favorably as it continues to innovate and improve healthcare delivery through investments in advanced technologies, including AI.
Leadership Insights
H.E. Kamal Al Maazmi, Chairman of PureHealth, expressed confidence in the company's trajectory. He noted, "Our journey towards becoming a leading global healthcare group is marked by the expanding strategic markets and enhanced local care capabilities. The dividends reflect our commitment to providing sustainable shareholder value while pursuing long-term growth opportunities."
Farhan Malik, Founder and Managing Director, further solidified this outlook, stating that the exceptional financial results led to strong shareholder returns and highlight PureHealth's aim of becoming a diversified international business with revenues shielded against market fluctuations.
Operational Highlights and Growth Areas
In its core markets, PureHealth has focused on scaling both its Care and Cover verticals. Notably, in the UK, Circle Health has shown impressive improvement through enhanced outpatient services. In Greece and Cyprus, the integration of HHG yielded USD 202 million in revenue during its fourth quarter of 2025, demonstrating the effectiveness of strategic acquisitions.
Continued Expansion and New Services
In the UAE, PureHealth broadened access to healthcare services by opening specialty clinics and enhancing existing healthcare infrastructure. Recent developments saw a notable rise in both inpatient and outpatient services, a testament to the increasing demand for quality healthcare.
On the insurance side, the Cover segment has seen robust growth, achieving a revenue increase of 13.5%, totaling USD 2.1 billion for FY 2025. This growth is largely driven by successful customer retention strategies and an increase in new enrolments, highlighting the market's ongoing recovery and expansion.
Innovations Driving Future Success
PureHealth remains committed to upgrading its service offerings through advanced digital healthcare tools. Significant achievements include launching virtual mental health services via an AI-enabled app and opening the UAE's largest AI-powered laboratory, which enhances diagnostic capabilities. These innovations are setting PureHealth apart as a leader in the evolving healthcare landscape.
As PureHealth moves into the next growth phase, the focus remains clear — to augment its international presence while fortifying its clinical specialties and enhancing operational efficiencies through continued AI investment.
Frequently Asked Questions
What was PureHealth's net profit for FY 2025?
PureHealth reported a net profit of USD 550 million for FY 2025.
How much is the proposed dividend for FY 2025?
The proposed dividend for FY 2025 is USD 163 million, representing about 30% of the net profit.
What factors contributed to PureHealth's revenue growth?
The growth was primarily supported by strong performances in the Healthcare and Insurance sectors and the acquisition of Hellenic Healthcare Group.
What regions does PureHealth operate in?
PureHealth operates in the UAE, USA, UK, Greece, and Cyprus.
What innovations is PureHealth implementing to enhance healthcare delivery?
PureHealth is implementing AI technologies, expanding diagnostic capabilities, and launching virtual healthcare services to enhance patient care.
